HIV-1 and HCV Infections among Antibody-Negative Blood Donors
- 18 November 2004
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (21) , 2232-2235
- https://doi.org/10.1056/nejm200411183512117
Abstract
As reported by Stramer et al. (Aug. 19 issue),1 testing for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) by nucleic acid amplification with the use of minipools has markedly reduced the transmission of HIV-1 and HCV through blood products. Testing of individual units is now being considered, but such a procedure would still not completely abolish transmission.2Keywords
This publication has 11 references indexed in Scilit:
- Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingNew England Journal of Medicine, 2004
- Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United StatesNew England Journal of Medicine, 2004
- The Safety and Availability of Blood and Tissues — Progress and ChallengesNew England Journal of Medicine, 2004
- Clostridium Infections Associated with Musculoskeletal-Tissue AllograftsNew England Journal of Medicine, 2004
- Survival after transfusion as assessed in a large multistate US cohortTransfusion, 2004
- Dynamics of HIV viremia and antibody seroconversion in plasma donorsAIDS, 2003
- The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donationsTransfusion, 2003
- Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionTransfusion, 2003
- Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000Transfusion, 2002
- Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNAThe Lancet, 2000